Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP928560.RAEhuX_nLeThygI_zExW897veg-90CVBb9fR0hTQQ455I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP928560.RAEhuX_nLeThygI_zExW897veg-90CVBb9fR0hTQQ455I130_assertion type Assertion NP928560.RAEhuX_nLeThygI_zExW897veg-90CVBb9fR0hTQQ455I130_head.
- NP928560.RAEhuX_nLeThygI_zExW897veg-90CVBb9fR0hTQQ455I130_assertion description "[In order to understand the mechanism underlying multidrug resistance in bladder cancer, we established three doxorubicin-resistant cell lines, T24/ADM-1, T24/ADM-2 and KK47/ADM, and one vincristine-resistant cell line, T24/VCR, from human bladder cancer T24 and KK47 cells respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP928560.RAEhuX_nLeThygI_zExW897veg-90CVBb9fR0hTQQ455I130_provenance.
- NP928560.RAEhuX_nLeThygI_zExW897veg-90CVBb9fR0hTQQ455I130_assertion evidence source_evidence_literature NP928560.RAEhuX_nLeThygI_zExW897veg-90CVBb9fR0hTQQ455I130_provenance.
- NP928560.RAEhuX_nLeThygI_zExW897veg-90CVBb9fR0hTQQ455I130_assertion SIO_000772 7734314 NP928560.RAEhuX_nLeThygI_zExW897veg-90CVBb9fR0hTQQ455I130_provenance.
- NP928560.RAEhuX_nLeThygI_zExW897veg-90CVBb9fR0hTQQ455I130_assertion wasDerivedFrom befree-20140225 NP928560.RAEhuX_nLeThygI_zExW897veg-90CVBb9fR0hTQQ455I130_provenance.
- NP928560.RAEhuX_nLeThygI_zExW897veg-90CVBb9fR0hTQQ455I130_assertion wasGeneratedBy ECO_0000203 NP928560.RAEhuX_nLeThygI_zExW897veg-90CVBb9fR0hTQQ455I130_provenance.